Ophthalmic devices are medical equipment that fulfils a medical purpose for use in optometry and ophthalmology. These devices range from non-invasive devices and instruments often used for diagnoses, to invasive devices, such as contact lenses (and their associated care products), and implantable devices, such as intraocular lenses and glaucoma stents. According to Gen Consulting Company, the global ophthalmic devices market is set to achieve an incremental growth of USD 19.8 billion, accelerating at a CAGR of almost 5.8% during the forecast period 2023-2029. The alarming increase in the prevalence of eye-related diseases such as glaucoma, cataract, refractive errors, and age-related macular degeneration (AMD) acts as a key factor contributing to the growth of the global ophthalmic devices market.The alarming increase in the prevalence of eye-related diseases such as glaucoma, cataract, refractive errors, and age-related macular degeneration (AMD) acts as a key factor contributing to the growth of the global ophthalmic devices market.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global ophthalmic devices market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, and region. The global market for ophthalmic devices can be segmented by product: ophthalmic diagnostic devices (autorefractors, corneal topography systems, fundus cameras, ophthalmoscopes, optical coherence tomography OCT, perimeters, retinal ultrasound imaging systems, slit lamps, tonometers, others), ophthalmic surgical devices (cataract surgery devices, glaucoma surgery devices, vitreoretinal surgery devices, refractive surgery devices), vision care devices (contact lenses, spectacle lenses). In 2022, the vision care devices segment made up the largest share of revenue generated by the ophthalmic devices market. Ophthalmic devices market is further segmented by region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America was the largest contributor to the global ophthalmic devices market in 2022.

The vision care devices market is further segmented into contact lenses, spectacle lenses. Among these, the spectacle lenses segment was accounted for the highest revenue generator in 2022. Furthermore, the contact lenses (by design) market has been categorized into multifocal lenses, spherical lenses, toric lenses, others. The spherical lenses segment captured the largest share of the market in 2022 and is expected to maintain its dominance during the forecast period. The contact lenses (by material) market is further divided into hybrid lenses, RGP lenses, soft lenses. According to the research, the soft lenses segment had the largest share in the global ophthalmic devices market. The ophthalmic surgical devices market is further segmented into cataract surgery devices, glaucoma surgery devices, vitreoretinal surgery devices, refractive surgery devices. Among these, the cataract surgery devices segment was accounted for the highest revenue generator in 2022. Furthermore, the ophthalmic diagnostic devices market has been categorized into autorefractors, corneal topography systems, fundus cameras, ophthalmoscopes, optical coherence tomography (OCT), perimeters, retinal ultrasound imaging systems, slit lamps, tonometers, others.

Market Segmentation
By product: ophthalmic diagnostic devices (autorefractors, corneal topography systems, fundus cameras, ophthalmoscopes, optical coherence tomography OCT, perimeters, retinal ultrasound imaging systems, slit lamps, tonometers, others), ophthalmic surgical devices (cataract surgery devices, glaucoma surgery devices, vitreoretinal surgery devices, refractive surgery devices), vision care devices (contact lenses, spectacle lenses)
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report also provides analysis of the key companies of the industry and their detailed company profiles including Alcon Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, CooperVision, Inc., Dutch Ophthalmic Research Center (International) B.V., Essilor International S.A. (EssilorLuxottica SA), Eyenuk, Inc., Glaukos Corporation, Haag-Streit Holding AG, Heidelberg Engineering GmbH, Hoya Corporation, IOPtima Ltd. (Chengdu Kanghong Pharmaceutical Group Co., Ltd.), IRIDEX Corporation, Johnson & Johnson, Lenstec, Inc., Lumenis Be Ltd., Nidek Co., Ltd., Oasis Medical, Inc., Quantel Medical SAS (LUMIBIRD SA), SAV-IOL SA, Shanghai Haohai Biological Technology Co., Ltd., Sight Sciences, Inc., STAAR Surgical Company, TissueTech, Inc. (Bio-Tissue Inc.), Topcon Corporation, Vasoptic Medical, Inc., Ziemer Ophthalmic Systems AG, among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global ophthalmic devices market.
• To classify and forecast the global ophthalmic devices market based on product, region.
• To identify drivers and challenges for the global ophthalmic devices market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global ophthalmic devices market.
• To identify and analyze the profile of leading players operating in the global ophthalmic devices market.

Why Choose This Report
• Gain a reliable outlook of the global ophthalmic devices market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.